Cargando…

SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage

Cells respond to DNA damage by activating a complex array of signaling networks, which include the AMPK and mTOR pathways. After DNA double-strand breakage, ATM, a core component of the DNA repair system, activates the AMPK-TSC2 pathway, leading to the inhibition of the mTOR cascade. Recently, we sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Lepore Signorile, Martina, Sanese, Paola, Di Nicola, Elisabetta, Fasano, Candida, Forte, Giovanna, De Marco, Katia, Disciglio, Vittoria, Latrofa, Marialaura, Pantaleo, Antonino, Varchi, Greta, Del Rio, Alberto, Grossi, Valentina, Simone, Cristiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670288/
https://www.ncbi.nlm.nih.gov/pubmed/37998381
http://dx.doi.org/10.3390/cells12222644
_version_ 1785149298146541568
author Lepore Signorile, Martina
Sanese, Paola
Di Nicola, Elisabetta
Fasano, Candida
Forte, Giovanna
De Marco, Katia
Disciglio, Vittoria
Latrofa, Marialaura
Pantaleo, Antonino
Varchi, Greta
Del Rio, Alberto
Grossi, Valentina
Simone, Cristiano
author_facet Lepore Signorile, Martina
Sanese, Paola
Di Nicola, Elisabetta
Fasano, Candida
Forte, Giovanna
De Marco, Katia
Disciglio, Vittoria
Latrofa, Marialaura
Pantaleo, Antonino
Varchi, Greta
Del Rio, Alberto
Grossi, Valentina
Simone, Cristiano
author_sort Lepore Signorile, Martina
collection PubMed
description Cells respond to DNA damage by activating a complex array of signaling networks, which include the AMPK and mTOR pathways. After DNA double-strand breakage, ATM, a core component of the DNA repair system, activates the AMPK-TSC2 pathway, leading to the inhibition of the mTOR cascade. Recently, we showed that both AMPK and mTOR interact with SMYD3, a methyltransferase involved in DNA damage response. In this study, through extensive molecular characterization of gastrointestinal and breast cancer cells, we found that SMYD3 is part of a multiprotein complex that is involved in DNA damage response and also comprises AMPK and mTOR. In particular, upon exposure to the double-strand break-inducing agent neocarzinostatin, SMYD3 pharmacological inhibition suppressed AMPK cascade activation and thereby promoted the mTOR pathway, which reveals the central role played by SMYD3 in the modulation of AMPK-mTOR signaling balance during cancer cell response to DNA double-strand breaks. Moreover, we found that SMYD3 can methylate AMPK at the evolutionarily conserved residues Lys411 and Lys424. Overall, our data revealed that SMYD3 can act as a bridge between the AMPK and mTOR pathways upon neocarzinostatin-induced DNA damage in gastrointestinal and breast cancer cells.
format Online
Article
Text
id pubmed-10670288
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106702882023-11-17 SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage Lepore Signorile, Martina Sanese, Paola Di Nicola, Elisabetta Fasano, Candida Forte, Giovanna De Marco, Katia Disciglio, Vittoria Latrofa, Marialaura Pantaleo, Antonino Varchi, Greta Del Rio, Alberto Grossi, Valentina Simone, Cristiano Cells Article Cells respond to DNA damage by activating a complex array of signaling networks, which include the AMPK and mTOR pathways. After DNA double-strand breakage, ATM, a core component of the DNA repair system, activates the AMPK-TSC2 pathway, leading to the inhibition of the mTOR cascade. Recently, we showed that both AMPK and mTOR interact with SMYD3, a methyltransferase involved in DNA damage response. In this study, through extensive molecular characterization of gastrointestinal and breast cancer cells, we found that SMYD3 is part of a multiprotein complex that is involved in DNA damage response and also comprises AMPK and mTOR. In particular, upon exposure to the double-strand break-inducing agent neocarzinostatin, SMYD3 pharmacological inhibition suppressed AMPK cascade activation and thereby promoted the mTOR pathway, which reveals the central role played by SMYD3 in the modulation of AMPK-mTOR signaling balance during cancer cell response to DNA double-strand breaks. Moreover, we found that SMYD3 can methylate AMPK at the evolutionarily conserved residues Lys411 and Lys424. Overall, our data revealed that SMYD3 can act as a bridge between the AMPK and mTOR pathways upon neocarzinostatin-induced DNA damage in gastrointestinal and breast cancer cells. MDPI 2023-11-17 /pmc/articles/PMC10670288/ /pubmed/37998381 http://dx.doi.org/10.3390/cells12222644 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lepore Signorile, Martina
Sanese, Paola
Di Nicola, Elisabetta
Fasano, Candida
Forte, Giovanna
De Marco, Katia
Disciglio, Vittoria
Latrofa, Marialaura
Pantaleo, Antonino
Varchi, Greta
Del Rio, Alberto
Grossi, Valentina
Simone, Cristiano
SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage
title SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage
title_full SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage
title_fullStr SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage
title_full_unstemmed SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage
title_short SMYD3 Modulates AMPK-mTOR Signaling Balance in Cancer Cell Response to DNA Damage
title_sort smyd3 modulates ampk-mtor signaling balance in cancer cell response to dna damage
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670288/
https://www.ncbi.nlm.nih.gov/pubmed/37998381
http://dx.doi.org/10.3390/cells12222644
work_keys_str_mv AT leporesignorilemartina smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage
AT sanesepaola smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage
AT dinicolaelisabetta smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage
AT fasanocandida smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage
AT fortegiovanna smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage
AT demarcokatia smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage
AT discigliovittoria smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage
AT latrofamarialaura smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage
AT pantaleoantonino smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage
AT varchigreta smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage
AT delrioalberto smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage
AT grossivalentina smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage
AT simonecristiano smyd3modulatesampkmtorsignalingbalanceincancercellresponsetodnadamage